Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply

Silvio Danese; Barrett G. Levesque; Brian G. Feagan; Alina Jucov; B. R. Bhandari; Rish K. Pai; Kristen Taylor Meadows; Brian J. Kirby; Jean Marie Bruey; Allan Olson; Robin Osterhout; Courtney Van Biene; Julia Ford; Richard Aranda; Kartik Raghupathi; William J. Sandborn

doi:10.1111/apt.16795

Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply

Silvio Danese, Barrett G. Levesque, Brian G. Feagan, Alina Jucov, B. R. Bhandari, Rish K. Pai, Kristen Taylor Meadows, Brian J. Kirby, Jean Marie Bruey, Allan Olson, Robin Osterhout, Courtney Van Biene, Julia Ford, Richard Aranda, Kartik Raghupathi, William J. Sandborn

Laboratory Medicine and Pathology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	735-736
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	55
Issue number	6
DOIs	https://doi.org/10.1111/apt.16795
State	Published - Mar 2022

ASJC Scopus subject areas

Hepatology
Gastroenterology
Pharmacology (medical)

Access to Document

10.1111/apt.16795

Cite this

Danese, S., Levesque, B. G., Feagan, B. G., Jucov, A., Bhandari, B. R., Pai, R. K., Meadows, K. T., Kirby, B. J., Bruey, J. M., Olson, A., Osterhout, R., Van Biene, C., Ford, J., Aranda, R., Raghupathi, K., & Sandborn, W. J. (2022). Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply. Alimentary Pharmacology and Therapeutics, 55(6), 735-736. https://doi.org/10.1111/apt.16795

Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply. / Danese, Silvio; Levesque, Barrett G.; Feagan, Brian G. et al.
In: Alimentary Pharmacology and Therapeutics, Vol. 55, No. 6, 03.2022, p. 735-736.

Research output: Contribution to journal › Editorial › peer-review

Danese, S, Levesque, BG, Feagan, BG, Jucov, A, Bhandari, BR, Pai, RK, Meadows, KT, Kirby, BJ, Bruey, JM, Olson, A, Osterhout, R, Van Biene, C, Ford, J, Aranda, R, Raghupathi, K & Sandborn, WJ 2022, 'Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply', Alimentary Pharmacology and Therapeutics, vol. 55, no. 6, pp. 735-736. https://doi.org/10.1111/apt.16795

@article{7c9daee1407f44c09b85cf05151e3cb8,

title = "Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply",

author = "Silvio Danese and Levesque, {Barrett G.} and Feagan, {Brian G.} and Alina Jucov and Bhandari, {B. R.} and Pai, {Rish K.} and Meadows, {Kristen Taylor} and Kirby, {Brian J.} and Bruey, {Jean Marie} and Allan Olson and Robin Osterhout and {Van Biene}, Courtney and Julia Ford and Richard Aranda and Kartik Raghupathi and Sandborn, {William J.}",

note = "Funding Information: The authors' declarations of personal and financial interests are unchanged from those in the original article.4",

year = "2022",

month = mar,

doi = "10.1111/apt.16795",

language = "English (US)",

volume = "55",

pages = "735--736",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Editorial

T2 - protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply

AU - Danese, Silvio

AU - Levesque, Barrett G.

AU - Feagan, Brian G.

AU - Jucov, Alina

AU - Bhandari, B. R.

AU - Pai, Rish K.

AU - Meadows, Kristen Taylor

AU - Kirby, Brian J.

AU - Bruey, Jean Marie

AU - Olson, Allan

AU - Osterhout, Robin

AU - Van Biene, Courtney

AU - Ford, Julia

AU - Aranda, Richard

AU - Raghupathi, Kartik

AU - Sandborn, William J.

N1 - Funding Information: The authors' declarations of personal and financial interests are unchanged from those in the original article.4

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85125764255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125764255&partnerID=8YFLogxK

U2 - 10.1111/apt.16795

DO - 10.1111/apt.16795

M3 - Editorial

C2 - 35245951

AN - SCOPUS:85125764255

SN - 0269-2813

VL - 55

SP - 735

EP - 736

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 6

ER -

Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004—a promising therapeutic approach for ulcerative colitis? Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this